Greenwich LifeSciences, Inc. - Common stock (GLSI) is listed on NASDAQ in the Manufacturing sector. This page tracks real-time GLSI price, technical indicators including RSI, MACD, and the 52-week range, plus fundamentals, earnings history, and recent insider trading activity.
Technical Analysis
RSI (14) 51.4 Neutral
Market Cap $247.5M
Volume 222.8K
Fundamentals — 10-Q Q2 2026
Revenue --
Net Income $-9.6M
EPS $-0.65
P/E Ratio -25.9x
Earnings
Recent Insider Trades
| Name | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| Patel Snehal | CEO and CFO | Buy | 2,200 | $13.43 | $29,555 | 2026 Jul 29 |
| Patel Snehal | CEO and CFO | Buy | 1,500 | $13.62 | $20,430 | 2026 Jul 27 |
| Patel Snehal | CEO and CFO | Buy | 3,600 | $13.06 | $47,018 | 2026 Jul 24 |
| Patel Snehal | CEO and CFO | Buy | 4,100 | $12.62 | $51,742 | 2025 Dec 18 |
| Patel Snehal | CEO and CFO | Buy | 4,600 | $8.37 | $38,502 | 2025 Nov 25 |
| Patel Snehal | CEO and CFO | Buy | 10,600 | $8.43 | $89,358 | 2025 Nov 7 |
| Patel Snehal | CEO and CFO | Buy | 2,300 | $9.26 | $21,298 | 2025 Oct 31 |
| Patel Snehal | CEO and CFO | Buy | 3,600 | $9.88 | $35,568 | 2025 Apr 25 |
| Patel Snehal | CEO and CFO | Buy | 5,400 | $8.98 | $48,492 | 2025 Apr 17 |
| Patel Snehal | CEO and CFO | Buy | 3,600 | $9.10 | $32,760 | 2025 Apr 7 |
| Patel Snehal | CEO and CFO | Buy | 5,500 | $8.73 | $48,015 | 2025 Apr 4 |
| Patel Snehal | CEO and CFO | Buy | 2,500 | $12.51 | $31,275 | 2025 Jan 10 |
| Patel Snehal | CEO and CFO | Buy | 2,900 | $13.58 | $39,391 | 2025 Jan 7 |
| Patel Snehal | CEO and CFO | Buy | 3,400 | $12.95 | $44,030 | 2025 Jan 3 |
| Patel Snehal | CEO and CFO | Buy | 2,000 | $11.97 | $23,940 | 2025 Jan 2 |
| Patel Snehal | CEO and CFO | Buy | 2,400 | $11.36 | $27,264 | 2024 Dec 31 |
| Patel Snehal | CEO and CFO | Buy | 3,200 | $11.12 | $35,584 | 2024 Dec 30 |
| Thompson Jaye | VP Clinical Reg Affairs | Buy | 1,000 | $12.91 | $12,910 | 2024 Nov 21 |
| Patel Snehal | CEO and CFO | Buy | 1,500 | $14.63 | $21,945 | 2024 Sep 26 |
| Thompson Jaye | VP Clinical Reg Affairs | Buy | 800 | $13.85 | $11,080 | 2024 Aug 12 |
Take GLSI further
- Browse Pharmaceutical Stocks for the rest of the group, with what the businesses in it have in common and where they differ.
- Put GLSI in a portfolio and see what it does to total return, drawdown, and how the rest of your holdings move with it. Compares against the S&P 500 over the same days, free and without an account.
- Screen for others like it by RSI, valuation, market cap, and insider activity.
- Check the earnings calendar for when Greenwich LifeSciences, Inc. - Common stock next reports.
Set alerts on GLSI
Get notified when Greenwich LifeSciences, Inc. - Common stock hits your price targets or technical conditions are met.
Get Started Free